Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production

Background  Highly pathogenic H5N1 avian influenza viruses currently circulating in birds have caused hundreds of human infections, and pose a significant pandemic threat. Vaccines are a major component of the public health preparedness for this likely event. The rapid evolution of H5N1 viruses has resulted in the emergence of multiple clades with distinct antigenic characteristics that require clade‐specific vaccines. A variant H5N1 virus termed clade 2.3.4 emerged in 2005 and has caused multiple fatal infections. Vaccine candidates that match the antigenic properties of variant viruses are necessary because inactivated influenza vaccines elicit strain‐specific protection.

[1]  Oie,et al.  Toward a Unified Nomenclature System for Highly Pathogenic Avian Influenza Virus (H5N1) , 2008, Emerging infectious diseases.

[2]  Gavin J. D. Smith,et al.  Antigenic Profile of Avian H5N1 Viruses in Asia from 2002 to 2007 , 2007, Journal of Virology.

[3]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[4]  A. Capuano,et al.  Infection due to 3 avian influenza subtypes in United States veterinarians. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  K. Subbarao,et al.  Scientific barriers to developing vaccines against avian influenza viruses , 2007, Nature Reviews Immunology.

[6]  Cecile Viboud,et al.  Correction: Stochastic Processes Are Key Determinants of Short-Term Evolution in Influenza A Virus , 2006, PLoS Pathogens.

[7]  K. Nichol,et al.  Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.

[8]  K. Subbarao,et al.  Emerging Respiratory Viruses: Challenges and Vaccine Strategies , 2006, Clinical Microbiology Reviews.

[9]  G. Dumyati,et al.  Influenza and Other Respiratory Viruses , 2006 .

[10]  N. Cox,et al.  Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model , 2006, Proceedings of the National Academy of Sciences.

[11]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[12]  Hongjie Yu,et al.  Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. , 2006, The New England journal of medicine.

[13]  Keiji Fukuda,et al.  Evolution of H5N1 Avian Influenza Viruses in Asia , 2005, Emerging infectious diseases.

[14]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[15]  Yoshihiro Kawaoka,et al.  Influenza: lessons from past pandemics, warnings from current incidents , 2005, Nature Reviews Microbiology.

[16]  J. Wood,et al.  Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. , 2005, Vaccine.

[17]  Albert D. M. E. Osterhaus,et al.  Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls , 2005, Journal of Virology.

[18]  A. Charlett,et al.  Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. , 2004, Virus research.

[19]  N. Cox,et al.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. , 2003, Virology.

[20]  A. Douglas,et al.  The evolution of human influenza viruses. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  Y. Guan,et al.  Universal primer set for the full-length amplification of all influenza A viruses , 2001, Archives of Virology.

[22]  W. J. Bean,et al.  Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. , 1993, Virology.

[23]  R. Couch,et al.  Influenza: its control in persons and populations. , 1986, The Journal of infectious diseases.

[24]  H. Klenk,et al.  The cleavage site of the hemagglutinin of fowl plague virus. , 1982, Virology.

[25]  C. Scholtissek,et al.  On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.

[26]  H. Klenk,et al.  Activation of influenza A viruses by trypsin treatment. , 1975, Virology.

[27]  A. S. Beare,et al.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses , 1972, Epidemiology and Infection.

[28]  G. K. Hirst.  THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS. , 1941, Science.

[29]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[30]  M. Pantin-Jackwood,et al.  Pathogenicity of avian influenza viruses in poultry. , 2006, Developments in biologicals.

[31]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[32]  P. Minor,et al.  WHO Expert Committee on Biological Standardization. , 2004, World Health Organization technical report series.